Towa Pharmaceutical Co (JP:4553) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Towa Pharmaceutical Co., Ltd. has reached a settlement in a patent infringement lawsuit filed by Eagle Pharmaceuticals, Inc. and SymBio Pharmaceuticals Limited concerning two of its intravenous infusion products. The lawsuit, initiated in December 2022, has been resolved with undisclosed terms, and Towa Pharmaceutical will continue to manufacture and sell the products with minimal impact on its consolidated financial results.
For further insights into JP:4553 stock, check out TipRanks’ Stock Analysis page.
